Tilman Sauerbruch
Overview
Explore the profile of Tilman Sauerbruch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
270
Citations
5003
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
51.
Nischalke H, Berger C, Lutz P, Langhans B, Wolter F, Eisenhardt M, et al.
PLoS One
. 2013 Nov;
8(11):e80848.
PMID: 24260493
Background And Aims: CXCL1 (CXC chemokine-ligand-1) is a ligand for CXC chemokine receptor 2 expressed on hepatic stellate cells (HSC). Thus, CXCL1 might contribute to HSC activation and fibrogenesis. In...
52.
Vogt A, Sievers E, Lukacs-Kornek V, Decker G, Raskopf E, Meumann N, et al.
Liver Int
. 2013 Sep;
34(3):447-61.
PMID: 23998316
Background: Interleukin 12 (IL-12), one of the most potent Th1-cytokines, has been used to improve dendritic cells (DC)-based immunotherapy of cancer. However, it failed to achieve clinical response in patients...
53.
Schierwagen R, Leeming D, Klein S, Granzow M, Nielsen M, Sauerbruch T, et al.
Front Physiol
. 2013 Aug;
4:195.
PMID: 23908632
Background: Progression of liver fibrosis is characterized by synthesis and degradation of extracellular matrix (ECM). Matrix-metalloproteinases (MMP) cleave collagen fibers at a specific site and thereby generate soluble fragments of...
54.
Grace J, Klein S, Herath C, Granzow M, Schierwagen R, Masing N, et al.
Gastroenterology
. 2013 Jun;
145(4):874-884.e5.
PMID: 23796456
Background & Aims: Splanchnic vascular hypocontractility with subsequent increased portal venous inflow leads to portal hypertension. Although the renin-angiotensin system contributes to fibrogenesis and increased hepatic resistance in patients with...
55.
56.
Glassner A, Eisenhardt M, Kokordelis P, Kramer B, Wolter F, Nischalke H, et al.
J Hepatol
. 2013 May;
59(3):427-33.
PMID: 23665286
Background & Aims: HIV/HCV co-infection is characterized by a faster progression to liver fibrosis compared to HCV mono-infection. Epidemiologic studies found an association between low CD4(+) T cell counts and...
57.
Sauerbruch T, Appenrodt B, Schmitz V, Spengler U
Dtsch Arztebl Int
. 2013 Mar;
110(8):126-32, I.
PMID: 23505400
Background: It is estimated that 1 million persons in Germany suffer from hepatic cirrhosis, which is the final stage of chronic inflammation of the liver. Cirrhosis has multiple causes, all...
58.
Lutz P, Strunk H, Schild H, Sauerbruch T
World J Gastroenterol
. 2013 Mar;
19(7):1140-2.
PMID: 23467463
A pleural effusion containing chylomicrons is termed chylothorax and results from leakage of lymph fluid into the pleural cavity. We report on the case of a 59-year-old woman with severe...
59.
Bellot P, Welker M, Soriano G, von Schaewen M, Appenrodt B, Wiest R, et al.
J Hepatol
. 2013 Jan;
58(5):922-7.
PMID: 23318604
Background & Aims: Refractory ascites (RA) affects 10% of patients with advanced cirrhosis and ascites. Usual therapy includes large volume paracentesis, and in selected patients, a transjugular portosystemic shunt (TIPS)....
60.
Banares R, Nevens F, Larsen F, Jalan R, Albillos A, Dollinger M, et al.
Hepatology
. 2012 Dec;
57(3):1153-62.
PMID: 23213075
Unlabelled: Acute-on-chronic liver failure (ACLF) is a frequent cause of death in cirrhosis. Albumin dialysis with the molecular adsorbent recirculating system (MARS) decreases retained substances and improves hemodynamics and hepatic...